Follow
Andreas Alvin Purnomo Soetedjo
Andreas Alvin Purnomo Soetedjo
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells
LSW Loo, AAP Soetedjo, HH Lau, NHJ Ng, S Ghosh, L Nguyen, ...
Cell death & disease 11 (5), 378, 2020
392020
Tissue engineering and 3D printing of bioartificial pancreas for regenerative medicine in diabetes
AAP Soetedjo, JM Lee, HH Lau, GL Goh, J An, Y Koh, WY Yeong, ...
Trends in Endocrinology & Metabolism 32 (8), 609-622, 2021
282021
Tools for bioimaging pancreatic β cells in diabetes
NY Kang, AAP Soetedjo, NS Amirruddin, YT Chang, O Eriksson, AKK Teo
Trends in Molecular Medicine 25 (8), 708-722, 2019
282019
Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency
EEK Tan, RA Hopkins, CK Lim, SS Jamuar, C Ong, KC Thoon, MJA Koh, ...
The Journal of Clinical Investigation 130 (11), 5817-5832, 2020
202020
Dynamic proteome profiling of human pluripotent stem cell-derived pancreatic progenitors
LSW Loo, H Vethe, AAP Soetedjo, JA Paulo, J Jasmen, N Jackson, ...
Stem Cells 38 (4), 542-555, 2020
72020
A new perspective of probe development for imaging pancreatic beta cell in vivo
CWY Neo, LM Ciaramicoli, AAP Soetedjo, AKK Teo, NY Kang
Seminars in Cell & Developmental Biology 103, 3-13, 2020
62020
BCL-xL/BCL2L1 Is a Critical Anti-Apoptotic Protein that Suppresses BAK to Promote Pancreatic Specification from Human Pluripotent Stem Cells
LSW Loo, A Teo, S Ghosh, AAP Soetedjo, L Nguyen, VG Krishnan, ...
DIABETES 68, 2019
2019
326-LB: BCL-xL/BCL2L1 Is a Critical Anti-Apoptotic Protein that Suppresses BAK to Promote Pancreatic Specification from Human Pluripotent Stem Cells
L SAI WENG LOO, A TEO, S GHOSH, A ALVIN PURNOMO SOETEDJO, ...
Diabetes 68 (Supplement_1), 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8